Topic: Three-target Diagnosis and Treatment of Late-stage Lung Cancer

John Jin Hong Liu, R.Ac & RTCMP, PhD


Master’s degree in Acupuncture
Doctor’s degree in TCM Oncology,
Principal of John & Jenny TCM College
Vice-president of The Alliance of Acupuncture and Chinese Medicine of Canada (AACMC)
Honored researcher at International Collaboration Centre of TCM Clinical Research (Canada)
Council member of Canadian Association of Cancer Support
Guest professor at Nanjing University of Chinese Medicine teaching TCM Classical literatures
John Jin Hong Liu, R.Ac & RTCMP received his bachelor degree in Traditional Chinese Medicine from Nanjing University of TCM, his master degree in Acupuncture and his doctor degree in TCM Internal Medicine(Oncology) from Zhejiang Chinese Medical University.
He is the principal of John & Jenny TCM College, president of John & Jenny TCM Clinic Centre, and Director of John & Jenny TCM Cancer Centre, vice-president of The Alliance of Acupuncture and Chinese Medicine of Canada (AACMC) , honoured researcher at International Collaboration Centre of TCM Clinical Research (Canada) ,council member of Canadian Association of Cancer Support, currently guest professor at Nanjing University of Chinese Medicine teaching TCM classical literatures and previously professor at Zhejiang University of Traditional Chinese Medicine and a medical doctor at its affiliated TCM Hospital.
He started to clinically practice Chinese medicine from 1988, using acupuncture and Chinese medicine to treat various pain disorders, paralytic diseases, rheumatoid arthritis, lupus erythematosus and other autoimmune diseases. He is the founder of TCM and Acupuncture Combined Target Treatment and Three-level Target Diagnostic Method
inventor of various acupuncture needling techniques including “one-needle multi-directional needling technique ”, “five constituent needling technique” and “heaven-earth qi-moving needling technique” and has written 2 books – “ TCM and Acupuncture Combined Clinical Essentials I & II”. He also successfully applied the unique acupuncture and Chinese medicine target treatment to tumour, internal medicine and gynecology. The results are clinically proven to be significant. Dr. Liu has won many advanced science and technology awards in the departmental and provincial level. He published up to sixty essays on professional magazines both at home and aboard, participated in the writing of many professional books and was one of the judges for the Chinese National Science Foundation. His project, The Analysis of Acupuncture and Chinese Medicine Target Treatment, was strongly supported by the Chinese National Science Foundation and the Zhejiang Provincial Health Care Outstanding Scholarship.


Late-stage lung cancer refers to metastatic lung cancer that has spread to distant organs in the body. Western medicine believes that the primary lesion is in the lung, and the secondary (metastatic) lesions are in tissues and organs of liver, brain, bones and so on.
Traditional Chinese medicine believes that the root cause of the disease is in the liver, spleen, and kidney, and the manifestation is in the lung, liver, brain, bone, and other lesion sites. Three-target diagnosis: The first target is located in the lung, liver, brain, or bone, with pathological nature of excess cold or excess heat. The second target is in the Foot Jueyin Meridian or Foot Shaoyin Meridian, with pathological nature of a mix of deficiency and excess, cold and heat. The third target is in the spleen, liver, or kidney, with pathological nature of deficiency and cold.

Targeted treatment with acupuncture and herbal medicine: For the first target, local subcutaneous surrounding acupuncture and moxibustion, surrounding fire acupuncture, topical herbal application followed by moxibustion, or plum blossom needle tapping can be performed. For the second target, acupuncture with regulating manipulation on the Jing-river points on affected channels can be used. For those with pain, the dragon and tiger battle or the Qian Kun Nuo Qi needle technique can be used. For the third target, the yuan-source point of affected organ can be needled with warm tonifying techniques and moxibustion. For spleen deficiency, modified Li Zhong Tang can be used; for kidney deficiency, modified Si Ni Tang can be used; and for liver deficiency, modified Wu Zhu Yu Tang can be used.
In addition, three clinical cases are included as examples.


Only Alliance Members or Conference Register Members could access the video recording, if you are a member please login to watch it, if you are not a member yet please sign up. St Mary’s Road, Winnipeg, MB, R3C 1L7

Copyright 2022 AACMC © All rights reserved. Develop by AT-Digital